US 11576983
Treatments for retinal disease
granted A61KA61K48/0016A61K48/0025
Quick answer
US patent 11576983 (Treatments for retinal disease) held by 4D MOLECULAR THERAPEUTICS INC. expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- 4D MOLECULAR THERAPEUTICS INC.
- Grant date
- Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K48/0016, A61K48/0025, A61K48/0058, A61K48/0075